Alicia Nicole Rizzo, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glycocalyx | 3 | 2023 | 88 | 1.540 |
Why?
|
Lung Injury | 2 | 2023 | 436 | 1.150 |
Why?
|
Sepsis | 4 | 2022 | 2593 | 0.770 |
Why?
|
Pulmonary Atelectasis | 1 | 2022 | 145 | 0.760 |
Why?
|
Capillary Permeability | 5 | 2022 | 798 | 0.740 |
Why?
|
Glycosaminoglycans | 1 | 2022 | 624 | 0.660 |
Why?
|
Microvessels | 1 | 2020 | 544 | 0.530 |
Why?
|
Lipopolysaccharides | 2 | 2020 | 2216 | 0.500 |
Why?
|
Acute Lung Injury | 2 | 2015 | 380 | 0.490 |
Why?
|
Lung | 8 | 2023 | 9857 | 0.490 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2015 | 146 | 0.490 |
Why?
|
Respiratory Insufficiency | 1 | 2023 | 1199 | 0.480 |
Why?
|
Pulmonary Artery | 2 | 2020 | 1912 | 0.460 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2020 | 2455 | 0.370 |
Why?
|
Benzamides | 1 | 2015 | 1379 | 0.340 |
Why?
|
Myosin-Light-Chain Kinase | 2 | 2018 | 100 | 0.280 |
Why?
|
Piperazines | 1 | 2015 | 2488 | 0.240 |
Why?
|
Cortactin | 3 | 2022 | 31 | 0.230 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2725 | 0.230 |
Why?
|
Pyrimidines | 1 | 2015 | 2943 | 0.220 |
Why?
|
Endothelial Cells | 4 | 2021 | 3486 | 0.190 |
Why?
|
Heparitin Sulfate | 2 | 2023 | 225 | 0.190 |
Why?
|
Pneumonia, Bacterial | 1 | 2023 | 316 | 0.190 |
Why?
|
Myosin Light Chains | 1 | 2020 | 121 | 0.180 |
Why?
|
Adherens Junctions | 1 | 2020 | 90 | 0.180 |
Why?
|
Phosphorylation | 4 | 2020 | 8436 | 0.170 |
Why?
|
Bronchoalveolar Lavage Fluid | 3 | 2015 | 768 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5534 | 0.160 |
Why?
|
Pseudogenes | 1 | 2018 | 113 | 0.160 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2569 | 0.150 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 687 | 0.150 |
Why?
|
von Willebrand Factor | 1 | 2021 | 669 | 0.140 |
Why?
|
Inflammation | 2 | 2015 | 10637 | 0.140 |
Why?
|
Syndecan-1 | 1 | 2017 | 165 | 0.140 |
Why?
|
Electric Impedance | 1 | 2020 | 729 | 0.140 |
Why?
|
Connexin 43 | 1 | 2015 | 207 | 0.120 |
Why?
|
Superoxides | 1 | 2015 | 387 | 0.120 |
Why?
|
Protective Agents | 1 | 2015 | 156 | 0.120 |
Why?
|
Ventilator-Induced Lung Injury | 1 | 2015 | 122 | 0.120 |
Why?
|
Ovalbumin | 1 | 2015 | 719 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.110 |
Why?
|
Calcium-Binding Proteins | 1 | 2018 | 1081 | 0.110 |
Why?
|
Listeriosis | 1 | 2014 | 149 | 0.110 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2015 | 689 | 0.110 |
Why?
|
Listeria monocytogenes | 1 | 2014 | 250 | 0.110 |
Why?
|
Animals | 11 | 2023 | 168768 | 0.100 |
Why?
|
Bacterial Vaccines | 1 | 2014 | 403 | 0.100 |
Why?
|
Serine | 1 | 2015 | 826 | 0.100 |
Why?
|
Endothelium | 1 | 2014 | 778 | 0.100 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2014 | 434 | 0.100 |
Why?
|
Nitric Oxide Synthase | 1 | 2014 | 915 | 0.100 |
Why?
|
Simvastatin | 1 | 2014 | 360 | 0.100 |
Why?
|
Mice | 7 | 2023 | 81201 | 0.100 |
Why?
|
Oxidation-Reduction | 1 | 2015 | 2184 | 0.090 |
Why?
|
Cells, Cultured | 4 | 2020 | 19233 | 0.090 |
Why?
|
Immunization | 1 | 2014 | 1256 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2917 | 0.090 |
Why?
|
Cytoskeleton | 1 | 2014 | 1185 | 0.080 |
Why?
|
Antigens, Bacterial | 1 | 2014 | 1172 | 0.080 |
Why?
|
Sex Factors | 1 | 2022 | 10400 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2014 | 1348 | 0.080 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2015 | 4424 | 0.070 |
Why?
|
NF-kappa B | 1 | 2015 | 2499 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2018 | 2542 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2015 | 2969 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4222 | 0.070 |
Why?
|
T-Lymphocyte Subsets | 1 | 2014 | 1837 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2022 | 15078 | 0.070 |
Why?
|
Humans | 13 | 2023 | 744366 | 0.070 |
Why?
|
Signal Transduction | 2 | 2020 | 23404 | 0.060 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18034 | 0.060 |
Why?
|
Cathelicidins | 1 | 2023 | 80 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19905 | 0.060 |
Why?
|
Oligosaccharides | 1 | 2023 | 414 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2023 | 362 | 0.050 |
Why?
|
Prognosis | 1 | 2022 | 29060 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2016 | 3444 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 21833 | 0.050 |
Why?
|
Cattle | 2 | 2015 | 3922 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9584 | 0.040 |
Why?
|
Asthma | 1 | 2015 | 6010 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2015 | 6386 | 0.030 |
Why?
|
Male | 3 | 2022 | 350115 | 0.030 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 2015 | 165 | 0.030 |
Why?
|
Interleukin-5 | 1 | 2015 | 273 | 0.030 |
Why?
|
Calmodulin | 1 | 2015 | 209 | 0.030 |
Why?
|
Proline-Rich Protein Domains | 1 | 2014 | 5 | 0.030 |
Why?
|
Kymography | 1 | 2014 | 14 | 0.030 |
Why?
|
Stress Fibers | 1 | 2014 | 57 | 0.030 |
Why?
|
Peptide Termination Factors | 1 | 2014 | 55 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2015 | 274 | 0.030 |
Why?
|
Heme | 1 | 2015 | 307 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2015 | 389 | 0.030 |
Why?
|
Vaccines, Attenuated | 1 | 2014 | 342 | 0.030 |
Why?
|
Enzymes | 1 | 2014 | 266 | 0.030 |
Why?
|
Protein Phosphatase 2 | 1 | 2014 | 229 | 0.030 |
Why?
|
Dimerization | 1 | 2014 | 895 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 343 | 0.030 |
Why?
|
Oncogenes | 1 | 2018 | 1265 | 0.030 |
Why?
|
Sphingosine | 1 | 2014 | 307 | 0.030 |
Why?
|
Interleukin-4 | 1 | 2015 | 1147 | 0.030 |
Why?
|
Lysophospholipids | 1 | 2014 | 331 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2014 | 475 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2014 | 906 | 0.030 |
Why?
|
Thrombin | 1 | 2014 | 598 | 0.030 |
Why?
|
Female | 3 | 2022 | 380193 | 0.020 |
Why?
|
Tight Junctions | 1 | 2014 | 311 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1723 | 0.020 |
Why?
|
Cysteine | 1 | 2015 | 873 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2022 | 15520 | 0.020 |
Why?
|
Virulence | 1 | 2014 | 1333 | 0.020 |
Why?
|
Ubiquitination | 1 | 2014 | 1012 | 0.020 |
Why?
|
Cadherins | 1 | 2014 | 907 | 0.020 |
Why?
|
Actins | 1 | 2016 | 2121 | 0.020 |
Why?
|
beta Catenin | 1 | 2014 | 1059 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2015 | 63107 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3848 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2014 | 1335 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2014 | 2377 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1539 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2700 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5218 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5895 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2014 | 3207 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7182 | 0.020 |
Why?
|
Binding Sites | 1 | 2014 | 6111 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7798 | 0.020 |
Why?
|
Cell Membrane | 1 | 2014 | 3749 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15535 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4026 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10483 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16690 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2014 | 3854 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 21748 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 13035 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5660 | 0.010 |
Why?
|
Cytokines | 1 | 2014 | 7323 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2018 | 6773 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 12073 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40075 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 72296 | 0.010 |
Why?
|
Mutation | 1 | 2015 | 29786 | 0.010 |
Why?
|